GenomeDx Announces Exclusive Marketing and Distribution Agreement for the Decipher Prostate Cancer Classifier in Israel and the Palestinian Authority

GenomeDx Reveals Exclusive Advertising and marketing and also Circulation Agreement for the Decipher Prostate Cancer Classifier in Israel …

12:09 GMT

PR Newswire SAN DIEGO, June 30, 2015 SAN DIEGO, June 30, 2015/ PRNewswire/– GenomeDx Biosciences today revealed that the business signed an unique arrangement with Medison Pharma Ltd., a leading online marketer of innovative medical care remedies, to distribute the Decipher ® Prostate Cancer cells Classifier in Israel and the Palestinian Authority. “The partnership with GenomeDx marks an … (continue reviewing)